Variation in global COVID-19 symptoms by geography and by chronic disease: A global survey using the COVID-19 Symptom Mapper
Articles
[키워드] Asthma
Asymptomatic COVID-19
Bayer
career
challenge
chronic disease
Chronic diseases
Clinical diagnosis
collaboration
Comorbidities
conducted
contribute
cough
country
COVID symptom profile
COVID symptoms mapper
COVID symptoms survey
COVID-19
COVID-19 symptom
COVID-19 symptoms
COVID-19, The Coronavirus Disease that first appeared in 2019 caused by the SARS-CoV-2 coronavirus.
Department
development
example
exploratory study
expressed
eye
failure
Fever
finding
foundation
funding
Future
geographic location
geographical location
greater
GSK
headache
Imperial College London
India
Industrial
Innovation
IQVIA
London
loss of taste
MRC
NIHR
outcome
Patient
PCR, polymerase chain reaction
positive
positive COVID-19
predict
profile
prognostic
proportion
public health messaging
reported
reported symptom
respiratory
Responder
responders
risk of infection
Shortness of breath
Spread
statistical
Strategy
suffered
Support
supported
Symptom
tested
the SARS-CoV-2 virus
Treatment
variant
Variation
WHO, World Health Organization, a specialized agency of the United Nations responsible for international public health.
[DOI] 10.1016/j.eclinm.2022.101317 PMC 바로가기 [Article Type] Articles
[DOI] 10.1016/j.eclinm.2022.101317 PMC 바로가기 [Article Type] Articles